As reported before, Dextreatment increases the myocilin expression (Figure 4A) (MYOC gene (Figure 5)), an HTMC marker whose overexpression isrelated to glaucoma cases.45,46 Moreover, an increasein ECM proteins, F-actin fibers, and focal adhesions was also observedas expected, with higher MFI levels in collagen IV, fibronectin, vimentin,F-actin fiber, and β-catenin signals. The gene discussed is FN1; the disease is glaucoma.